Lopinavir CAS 192725-17-0 API Atako-HIV HIV Idaabobo Idalọwọduro COVID-19 Mimọ Giga
Ipese Olupese pẹlu Iwa-mimọ giga ati Didara Idurosinsin
Orukọ Kemikali: Lopinavir
CAS: 192725-17-0
Alagbara Giga, Ayanfẹ Peptidomitic HIV-1 Inhibitor Protease
Ọja Iwadi ibatan COVID-19
API Didara Giga, Iṣelọpọ Iṣowo
Orukọ Kemikali | Lopinavir |
Awọn itumọ ọrọ sisọ | LPV;ABT-378;Kaletra |
Nọmba CAS | 192725-17-0 |
NỌMBA CAT | RF-API73 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn ọgọọgọrun Kilogram |
Fọọmu Molecular | C37H48N4O5 |
Òṣuwọn Molikula | 628.81 |
Ibi ipamọ igba pipẹ | Tọju Igba pipẹ ni 2-8℃ |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Funfun to Pa-White Powder |
Solubility | Tiotuka larọwọto ni kẹmika ati ni Ethanol, Soluble ni 2-Propanol |
Idanimọ IR | Ifiweranṣẹ gbigba infurarẹẹdi ti ayẹwo idanwo jẹ ibamu pẹlu iwọn ti iwọn itọkasi |
HPLC idanimọ | Akoko idaduro ti ayẹwo idanwo ni ibamu si ti boṣewa itọkasi |
Akoonu Omi (nipasẹ KF) | ≤4.0% |
Specific Optical Yiyi | -22,0 ° to -26,0 ° |
Aloku lori Iginisonu | ≤0.20% |
Awọn irin Heavy | ≤20ppm |
Ojuami Iyo | 124.0 si 127.0 ℃ |
Sulfated Ash | ≤0.20% |
Ohun elo ti o ku (Ethanol) | ≤0.50% |
Awọn nkan ti o jọmọ | (HPLC, Agbegbe%) |
Aimọ́ 1 | |
Àìmọ́ B (RRT=0.07) | ≤0.20% |
Aimọ I (RRT=1.10) | ≤0.20% |
Eyikeyi Iwa Aimọ | ≤0.10% |
Aimọ́ 2 | Eyikeyi Iwa Aimọ Olukuluku ≤0.10% |
Lapapọ Awọn aimọ lati Ilana 1 ati 2 | ≤0.70% |
Lapapọ Awọn Aimọ | ≤1.0% |
Ayẹwo (nipasẹ HPLC) | 98.0% ~ 102.0% |
Igbeyewo Standard | Standard Enterprise |
Lilo | Yiyan Peptidomitic HIV-1 Inhibitor Protease, Ọja Iwadi ibatan COVID-19 |
Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.
Lopinavir (ABT-378) jẹ alagbara ti o ga julọ, oludanu peptidomitic ti o yan ti protease HIV-1, pẹlu Kis ti 1.3 si 3.6 pM fun iru-igi ati ọlọjẹ ọlọjẹ HIV.Lopinavir ṣiṣẹ nipa didimu idagbasoke ti HIV-1 nitorinaa dina aarun ayọkẹlẹ rẹ.Lopinavir tun jẹ inhibitor SARS-CoV 3CLpro pẹlu IC50 ti 14.2 μM.Lopinavir jẹ antiretroviral ti kilasi inhibitor protease.Idinamọ ti HIV-1 protease ṣe idilọwọ didasilẹ ti iṣaju polyprotein gbogun ati awọn abajade ni itusilẹ ti ko dagba, awọn virions ti ko ni akoran.Apakan ti itọju ailera apapọ lati tọju HIV/AIDS.Lopinavir, oludena protease HIV kẹfa ni kilasi “navir”, ni a ṣe ifilọlẹ ni ibamu pẹlu ritonavir, inhibitor protease HIV miiran ti o ta ọja tẹlẹ (Abbott, 1996);Ilana atilẹba yii ni a ṣe bi Kaletra fun lilo ni apapo pẹlu boya nucleoside tabi awọn inhibitors transscriptase ti kii-nucleoside fun itọju AIDS ni awọn agbalagba ati awọn ọmọde.Lopinavir jẹ agbo peptidomimetic kan pẹlu ipilẹ igbekalẹ ti o jọra si ti ritonavir, lori eyiti awọn ẹgbẹ ebute, paapaa valine ti a ti yipada, ti ṣafihan nipasẹ awọn ilana isọpọ peptide.Lopinavir jẹ oludaniloju ifigagbaga ti o lagbara ti HIV-I protease ti n ṣafihan agbara giga lodi si awọn iyipada sooro ritonavir.Ninu ọpọlọpọ awọn eya ẹranko, awọn iwadii elegbogi pẹlu ẹgbẹ lopinavirlritonavir fihan pe awọn ohun-ini iwọntunwọnsi ti lopinavir ni ilọsiwaju ni pataki niwaju ritonavir, ni awọn ofin ti Cmax ati iye akoko iṣe.